Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy Clinical Trials in New York, New York

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy